糖尿病與類流感腸病毒感染風險增加近10倍有關


  【24drs.com】根據一項發表在2月3日BMJ觀察性分子研究系統性綜論與綜合分析結果,第一型糖尿病與類流感腸病毒感染風險增加近10倍有關。
  
  新德里新南威爾斯大學的Wing-Chi G. Yeung與同事們寫到,第一型糖尿病被認為源自於基因易感性、免疫系統與環境因素之間複雜的交互作用。前瞻性研究也已經證實有胰島自體抗體或之後發生糖尿病、或兩者皆有的兒童,罹患腸病毒感染風險更高;且感染與自體免疫之間有時序上的關聯性。腸病毒感染與糖尿病之間的關係,在每個研究不盡相同,因此,這個課題仍然存有爭議。
  
  這項研究的目的在研究以分子檢驗診斷目前腸病毒感染以及自體免疫發展或第一型糖尿病之間的關連性。
  
  研究人員搜尋PubMed截至2010年5月、以及EMBASE截至2010年5月的人類研究,且不限制文獻語言,他們也搜尋文章的參考文獻,並且連絡作者。收納文章條件為世代或病例控制設計研究,測量糖尿病前期、糖尿病患者血液、糞便或組織樣本中腸病毒RNA或病毒蛋白量,這些研究必須有足夠數據才能計算勝算比(ORs)以及95%信賴區間(CIs)。
  
  總共有24篇文獻和2篇會議摘要符合上述條件;這些研究都是病例控制研究,共收納4,448位受試者;然而,試驗設計之間有很大差異,造成統計上顯著異質性。糖尿病相關自體免疫或第一型糖尿病被認為是兩個獨立預後。
  
  根據綜合分析的隨機模式分析結果,腸病毒感染顯著地與第一型糖尿病自體免疫有關(OR為3.7;95% CI為2.1-6.8;研究間異質性χ2/df = 1.3),也與臨床第一型糖尿病有關(OR為9.8;95% CI為5.5-17.4;研究間異質性χ2/df = 3.2)。
  
  試驗作者們寫到,以分子方法偵測的腸病毒感染,以及自體免疫/第一型糖尿病之間有顯著關係;需要更大型的前瞻性研究來建立腸病毒感染與發生自體免疫及第一型糖尿病之間的時序關連性。
  
  這項研究的限制包括觀察性研究的綜合分析無法證實因果關係、大部分收納研究來自於歐洲、研究設計與研究方法之間差異很大、以及可能未量測到的共同影響因子。除此之外,腸病毒聚合酶鍊反應引子之間的敏感性與專一性差異很大,且不是所有研究都有報告其聚合酶鍊反應確效或偵測極限的數據。
  
  在隨後的主編評論中,來自法國里爾第二大學的Didier Hober與Famara Sane表示,第一型糖尿病與腸病毒感染之間的關連性是很清楚的,但是機轉仍需要更多研究釐清。
  
  Hober與Sane博士寫到,腸病毒與第一型糖尿病病理生成之間的關係牽涉到病毒、胰臟貝他細胞、主動與被動免疫系統、以及患者基因型之間的相互影響。需要未來的研究進一步探討這些因素之間的關連性,並且建立腸病毒感染的病理機轉。腸病毒與第一型糖尿病之間的關係開啟了發展新對抗該疾病預防性及治療性策略的契機。
  
  這項研究未接受任何來自公開、商業或非營利機構的贊助。試驗作者們與主編們表示沒有相關資金上的往來。
  
  資料來源:http://www.24drs.com/professional/list/content.asp?x_idno=6458&x_classno=0&x_chkdelpoint=Y

Diabetes Linked to Nearly 10-Fold Increase in Cold-Like Enterovirus Infection

By Laurie Barclay, MD
Medscape Medical News

February 11, 2010 — Type 1 diabetes is linked to nearly a 10-fold increase in cold-like enterovirus infection, according to the results of a systematic review and meta-analysis of observational molecular studies reported in the February 3 issue of the BMJ.

"Type 1 diabetes is believed to result from a complex interplay between genetic predisposition, the immune system, and environmental factors," write Wing-Chi G. Yeung, from the University of New South Wales in Sydney, Australia, and colleagues. "...Prospective studies have also shown more enterovirus infections in children who developed islet autoantibodies or subsequent diabetes, or both; as well as a temporal relation between infection and autoimmunity. The relation between enterovirus infection and diabetes is not consistent across all studies, however, and the subject remains controversial."

The goal of the study was to examine the association between current enterovirus infection diagnosed with molecular testing and development of autoimmunity or type 1 diabetes.

The investigators searched PubMed to May 2010 and EMBASE to May 2010 for human studies without language restrictions. They also searched bibliographies of identified articles and contacted the study authors. Inclusion criteria for the studies were cohort or case-control design measuring enterovirus RNA or viral protein in blood, stool, or tissue of patients with prediabetes and diabetes, with sufficient data to calculate odds ratios (ORs) and 95% confidence intervals (CIs).

There were 24 studies and 2 abstracts meeting inclusion criteria; these were all case-control studies enrolling a total of 4448 participants. However, great variance in the study designs resulted in a high degree of statistical heterogeneity. Diabetes-related autoimmunity or type 1 diabetes was considered as 2 separate outcomes. Enterovirus infection was significantly associated with type 1 diabetes–related autoimmunity (OR, 3.7; 95% CI, 2.1 - 6.8; heterogeneity χ2/df = 1.3) and clinical type 1 diabetes (OR, 9.8; 95% CI, 5.5 - 17.4; heterogeneity χ2/df = 3.2), based on meta-analysis using random-effects models.

"There is a clinically significant association between enterovirus infection, detected with molecular methods, and autoimmunity/type 1 diabetes," the study authors write. "Larger prospective studies would be needed to establish a clear temporal relation between enterovirus infection and the development of autoimmunity and type 1 diabetes."

Limitations of this study include meta-analysis of observational studies unable to prove causality, high proportion of included studies from European countries, significant heterogeneity in study design and methods used, and possible unmeasured confounding factors. In addition, enterovirus polymerase chain reaction primers had varying sensitivity and specificity, and not all studies reported the validation and limits of detection of their polymerase chain reaction method.

In an accompanying editorial, Didier Hober and Famara Sane, from University Lille 2 in France, note that type 1 diabetes and enterovirus infection are clearly linked, but the mechanism is yet to be explained.

"The link between enteroviruses and the pathogenesis of type 1 diabetes probably involves an interplay between viruses, pancreatic beta cells, the innate and adaptive immune systems, and the genotype of the patient," Drs. Hober and Sane write. "Further studies are needed to tease out the association of these factors and to establish the pathogenic mechanisms of enterovirus infections. The association between enteroviruses and type 1 diabetes opens up the possibility of developing new preventive and therapeutic strategies to fight this disease."

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. The study authors and editorialists have disclosed no relevant financial relationships.

BMJ. 2011;342:d35.

    
相關報導
單靠篩檢與治療無法預防第二型糖尿病
2017/1/12 上午 11:07:07
別老是坐著 少坐一點對糖尿病有好處
2016/12/9 上午 10:05:25
Metformin失敗之後 延遲強化治療常見
2016/8/31 下午 01:57:15

上一頁
   1   2   3   4   5   6   7   8   9   10  




回上一頁